FDA Inspection
AnazaoHealth CorporationAnazaoHealth Corporation – FDA Inspection, Jul 29, 2022
Record Details
This FDA Inspection record concerns AnazaoHealth Corporation, with an inspection on July 29, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- AnazaoHealth Corporation
- Inspection Date
- July 29, 2022
- Product Type
- Drugs
View Company Profile
ID · 6873243f-c7eb-43c3-815f-34935ee41e29
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1177831
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AnazaoHealth Corporation
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 8, 2025 | OAI | San Francisco District Office | Drug Quality Assurance |
| September 23, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2017 | Not classified | San Francisco District Office | |
| January 30, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AnazaoHealth Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.